Frequently Asked Questions

Every product is independently tested in Australian laboratories — not supplier-certified — achieving 99%+ purity on every batch. We use HPLC (High-Performance Liquid Chromatography) and Mass Spectrometry testing methods. Full lab reports are available for every product on request.

99% purity means that 99% or more of the sample is the target peptide compound, as measured by HPLC analysis. The remaining fraction typically consists of minor synthesis by-products, counter-ions, or residual salts — all normal and expected in peptide synthesis. Higher purity means fewer contaminants and more reliable research outcomes.

Most peptide suppliers receive a Certificate of Analysis from their overseas manufacturer and pass it on as quality assurance. At Elite Peps Australia, we independently test every batch in Australian laboratories using HPLC and Mass Spectrometry after receiving the product. Our results come from our own testing, not a manufacturer's paperwork.

HPLC stands for High-Performance Liquid Chromatography. It is the gold standard analytical method for measuring peptide purity. HPLC separates the components of a sample and measures the proportion of the target peptide relative to any impurities. When we say a product is 99%+ purity, that number comes directly from HPLC analysis conducted in an Australian laboratory.

Mass Spectrometry confirms the molecular weight and identity of a peptide. While HPLC tells you how pure a sample is, Mass Spectrometry tells you what the sample actually is — verifying the compound matches the intended peptide. We conduct both HPLC and Mass Spectrometry on every batch.

Absolutely. Full HPLC and Mass Spectrometry lab reports are available for any product on request. Visit our Lab Reports page or email us at admin@elitepepsaustralia.com and we will send the report for your specific batch within 24 hours.

A Certificate of Analysis typically includes the peptide name and sequence, molecular weight confirmed by Mass Spectrometry, purity percentage measured by HPLC, the testing method used, batch or lot number, and date of analysis. The most important number to check is the purity percentage — should be 99% or above for research-grade peptides.

Any batch that fails to meet our 99%+ purity standard is rejected outright. No exceptions. We do not sell products that fail our quality threshold, regardless of what the manufacturer's own certificate states. We verify first and only release batches that pass both HPLC purity and Mass Spectrometry identity confirmation.

Peptides are short chains of amino acids — the same building blocks that make up proteins in your body. While proteins can contain hundreds or thousands of amino acids, peptides are much smaller, typically between 2 and 50 amino acids in length. Because of their small size, peptides can interact with specific receptors in the body with remarkable precision.

The primary difference is size. Peptides are short chains of amino acids (typically 2 to 50), while proteins are much larger (typically 50 or more amino acids folded into complex three-dimensional structures). Many hormones — including insulin, growth hormone releasing hormones, and GLP-1 — are peptides.

GLP-1 (glucagon-like peptide-1) peptides activate the GLP-1 receptor, which plays a key role in glucose metabolism, appetite regulation, and insulin secretion. Approved GLP-1 drugs include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Research peptides in this category include Retatrutide, a triple agonist targeting GLP-1, GIP, and Glucagon receptors simultaneously.

BPC-157 (Body Protection Compound) is primarily studied for tissue repair, gut mucosal protection, and inflammation modulation. TB-500 (Thymosin Beta-4 fragment) is studied for cell migration, wound healing, and systemic anti-inflammatory activity. They target different biological mechanisms and are frequently studied together — sometimes called the Wolverine Stack.

The Wolverine Stack is the popular name for the combination of BPC-157 and TB-500. BPC-157 works primarily through angiogenesis, collagen formation, and gut protection, while TB-500 works through cell migration and systemic tissue repair. We offer this combination as a pre-blended BPC-157 + TB-500 vial.

Retatrutide (LY3437943) is a triple agonist peptide that activates three receptors simultaneously: GLP-1, GIP, and Glucagon. Phase 2 clinical trial data showed 24.2% average body weight reduction at 48 weeks at the highest dose. Phase 3 trials are currently underway with results expected in late 2026. It is currently available as a research peptide only with no FDA or TGA approval.

Mitochondrial peptides target mitochondria — the energy-producing structures inside every cell. The most researched include SS-31 (Elamipretide), which stabilises the inner mitochondrial membrane, and MOTS-C, which activates AMPK metabolic signalling. This is one of the fastest-growing categories in longevity research.

GHK-Cu is a naturally occurring tripeptide bound to a copper ion, first identified in human plasma. Research shows it can modulate the expression of over 4,000 human genes. GHK-Cu levels decline significantly with age. Studies have explored its effects on collagen synthesis, wound healing, anti-inflammatory activity, and antioxidant function.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell, essential for cellular energy production, DNA repair, and activation of sirtuins linked to longevity. NAD+ levels naturally decline by approximately 50% between ages 40 and 60, associated with reduced cellular energy and accelerated aging processes.

Nootropic peptides are compounds studied for effects on cognitive function including memory, focus, anxiety, neuroprotection, and mental clarity. The most researched include Semax (studied for BDNF upregulation and memory formation) and Selank (studied for anxiolytic effects without sedation). Both were originally developed in Russia and have gained increasing attention in Western research.

Pharmaceutical peptides have completed full clinical trials, received regulatory approval, and are manufactured under strict pharmaceutical-grade conditions for human therapeutic use. Research peptides are used in laboratory settings, have not completed the full regulatory approval process, and are sold strictly for research purposes — not intended for human consumption.

Unreconstituted (lyophilized) peptides should be stored refrigerated between 2–8°C. For long-term storage, -20°C is recommended. Once reconstituted with bacteriostatic water, keep refrigerated at 2–8°C and use within 4–6 weeks. Avoid repeated freeze-thaw cycles as this can degrade the peptide structure.

Lyophilized peptides stored at 2–8°C typically remain stable for 12–24 months. Longer-term storage at -20°C can extend stability further. Once reconstituted with bacteriostatic water, use within 4–6 weeks and keep refrigerated. Always allow the vial to reach room temperature before opening to prevent moisture absorption.

Freezing reconstituted peptides is generally not recommended as ice crystal formation can damage the peptide structure. If longer storage is needed, divide the solution into smaller single-use aliquots before freezing so each aliquot only needs to be thawed once, avoiding repeated freeze-thaw cycles.

Signs of degradation include cloudiness or turbidity in the reconstituted solution, visible particles, unusual colour changes, or a strange smell. A properly reconstituted peptide should produce a clear, colourless solution. If any of these signs appear, discard the peptide as it will produce unreliable research results.

Lyophilized peptides are stable at ambient temperatures for short transit periods and do not require cold-chain shipping. The freeze-drying process protects the peptide during transport. We recommend refrigerating peptides as soon as they arrive to maintain optimal long-term stability.

Add bacteriostatic water slowly along the inside wall of the vial using a syringe — do not inject directly onto the peptide powder. Do not shake the vial. Gently swirl until fully dissolved. The solution should be clear and colourless when fully dissolved. Store reconstituted peptides refrigerated at 2–8°C and use within 4–6 weeks.

Bacteriostatic water (BAC water) is sterile water containing 0.9% benzyl alcohol as a preservative. The benzyl alcohol inhibits bacterial growth, making it safe for multiple withdrawals from the same vial. It is the standard diluent for reconstituting lyophilized research peptides. Never use tap water, distilled water, or saline to reconstitute peptides.

Yes. Every peptide order from Elite Peps Australia includes a free 10ml vial of bacteriostatic water for reconstitution purposes. Additional BAC water vials are also available for purchase separately.

The amount of bacteriostatic water determines the concentration of your reconstituted solution. A common guideline is to add 1–2ml of BAC water per 5mg of peptide. For example, adding 2ml of BAC water to a 10mg vial creates a concentration of 5mg/ml. The right amount depends on your specific research protocol requirements.

For proper reconstitution you will need: your lyophilized peptide vial, bacteriostatic water (included free with every order), alcohol swabs for sterilising vial tops, a syringe for drawing and transferring the BAC water (typically a 1ml or 3ml syringe), and a clean workspace. Always wash your hands thoroughly before use.

If the peptide does not dissolve immediately, allow more time — some peptides can take several minutes. Continue gently swirling the vial periodically. Do not shake vigorously. If the solution remains cloudy or contains visible particles after extended gentle mixing, the peptide may have degraded and should not be used.

Semaglutide (Ozempic/Wegovy) is a single GLP-1 receptor agonist. Retatrutide is a triple agonist simultaneously targeting GLP-1, GIP, and Glucagon receptors. In clinical trials, Retatrutide showed 24.2% average weight loss at 48 weeks at the highest dose, compared to approximately 15–17% for semaglutide. Semaglutide is TGA-approved; Retatrutide is available only as a research compound.

Tirzepatide (Mounjaro/Zepbound) is a dual agonist targeting GLP-1 and GIP receptors. Retatrutide adds a third receptor — the Glucagon receptor — making it a triple agonist. Phase 2 data showed Retatrutide achieving 24.2% weight loss at 48 weeks versus Tirzepatide's 22.5% at 72 weeks. Tirzepatide has TGA approval while Retatrutide remains in Phase 3 clinical trials.

CJC-1295 with DAC has an extended half-life of approximately 6–8 days, providing sustained growth hormone elevation. CJC-1295 without DAC (Mod GRF 1-29) has a much shorter half-life of approximately 30 minutes, producing shorter, more natural growth hormone pulses. The no-DAC version is often combined with Ipamorelin to more closely mimic the body's natural pulsatile growth hormone release pattern.

Semax is a synthetic derivative of ACTH fragment 4-10, primarily studied for cognitive enhancement and neuroprotective effects — it upregulates BDNF and is associated with improved memory and focus. Selank is a synthetic analogue of tuftsin, studied for anxiolytic effects without sedation or dependence. They are often studied together as they target complementary cognitive pathways.

SS-31 (Elamipretide) physically binds to cardiolipin in the inner mitochondrial membrane, protecting the structural integrity of the energy-producing machinery. MOTS-C works through AMPK signalling to improve metabolic function and fat oxidation. SS-31 protects existing mitochondrial structure while MOTS-C signals cells to build new mitochondrial capacity.

Peptide legality in Australia depends on the specific compound and its intended use. The TGA classifies most therapeutic peptides as Schedule 4 (prescription-only) medicines. Research peptides sold for laboratory and scientific purposes operate under different regulatory frameworks. All Elite Peps Australia products are sold strictly for research use only.

Schedule 4 of the Poisons Standard designates prescription-only medicines in Australia. This includes most therapeutic peptides such as BPC-157, TB-500, CJC-1295, Ipamorelin, Sermorelin, GHRP-6, Hexarelin, AOD-9604, HGH Fragment, and PT-141. BPC-157 was specifically added to Schedule 4 in June 2024 — Australia was the first country in the world to specifically schedule BPC-157.

In February 2026, the TGA reclassified Melanotan II from Schedule 4 to Schedule 9 — the same category as prohibited substances like MDMA. This was based on 89 adverse event reports between 2022 and 2025, including two melanoma cases within 18 months of use. Possession of Schedule 9 substances now carries criminal penalties in Australia.

The TGA (Therapeutic Goods Administration) is Australia's regulatory authority for medicines, medical devices, and biologicals. It determines which peptides require prescriptions (Schedule 4), which are prohibited (Schedule 9), and which are approved for sale. The TGA operates under the Therapeutic Goods Act 1989 and is equivalent to the FDA in the United States.

Yes. Any AHPRA-registered medical practitioner in Australia can prescribe Schedule 4 peptides, including GPs, integrative medicine practitioners, and specialists. Prescriptions are typically fulfilled through TGA-licensed compounding pharmacies. Telehealth consultations are legally equivalent to in-person consultations for prescribing Schedule 4 medicines across all Australian states and territories.

Products labelled "research use only" or "not for human consumption" are intended for laboratory and scientific research purposes. This designation means the products have not been evaluated or approved by the TGA for human therapeutic use and are not to be used for self-administration, diagnosis, treatment, or prevention of any medical condition.

The TGA regularly reviews substances based on adverse event reports, misuse patterns, and public health data. The trend over the past several years has been toward increased regulation, with more compounds being scheduled and enforcement intensifying. Researchers should stay informed about regulatory changes through the TGA website and official Poisons Standard updates.

Yes. We ship to all Australian states and territories including New South Wales, Victoria, Queensland, Western Australia, South Australia, Tasmania, Northern Territory, and the Australian Capital Territory — including regional and remote areas. Orders over $100 qualify for free express shipping. Same-day dispatch on orders placed before 2pm AEST (Monday–Friday).

Sydney metro: 1–2 business days. Melbourne, Brisbane, Perth, Adelaide metro: 2–4 business days. Regional and remote areas: 3–7 business days. All orders include tracking information sent to your email immediately upon dispatch.

Yes. Tracking information is emailed to you automatically once your order is dispatched. You can track your order at any time using the link in your confirmation email. If you have not received tracking information within 24 hours of placing your order on business days, please contact us at admin@elitepepsaustralia.com.

Yes. All orders are shipped in plain, unmarked packaging with no external branding or product descriptions visible. The sender details show our company name only. We take privacy seriously and ensure that no product information is visible on the outside of any shipment.

Currently, Elite Peps Australia focuses on serving the Australian research community with domestic shipping only. This allows us to maintain our quality standards, fast delivery times, and Australian lab testing processes. If you are outside Australia, please contact us to discuss potential options.

We accept all major credit cards (Visa, Mastercard, American Express), debit cards, Apple Pay, Google Pay, and bank transfer. All transactions are processed securely with full SSL encryption to protect your financial information.

Yes. Orders over $400 receive a 10% discount and orders over $600 receive a 20% discount. These are applied automatically at checkout — no discount code needed. These discounts can be combined with our free express shipping on orders over $100.

Yes. All transactions are processed using bank-level 256-bit SSL encryption. We never store your full credit card details on our servers. Our payment processing is PCI DSS Level 1 compliant — the highest level of payment security certification available.

No. All products sold by Elite Peps Australia are strictly for laboratory and scientific research purposes only. They are not intended for human consumption, therapeutic use, or self-administration. These products are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Research peptides are available to researchers, laboratories, scientific professionals, educational institutions, and independent researchers across Australia. Purchasers must comply with all applicable Australian laws and regulations regarding the purchase, possession, and use of research compounds.

As our products are sold strictly for research purposes, we do not provide dosing instructions for human use. We provide standard reconstitution guidance and storage instructions to ensure product integrity. For specific peptide research protocols, we recommend consulting published peer-reviewed literature available through databases such as PubMed.